Nexalin Technology (NXL) Retained Earnings (2021 - 2026)
Nexalin Technology's (NXL) quarterly Retained Earnings came in at $494.0 in Q1 2026, up 55.84% year-on-year from $317.0 in Q1 2025, and up 21.67% quarter-over-quarter from $406.0 in Q4 2025.
Nexalin Technology (NXL) Retained Earnings (2021 - 2026) Analysis & Trends
Nexalin Technology's Retained Earnings history runs 6 years deep, the most recent figure standing at $494.0 for Q1 2026.
- On a quarterly basis, Retained Earnings rose 55.84% year-over-year to $494.0 in Q1 2026; TTM through Mar 2026 was $494.0, a 55.84% increase from a year earlier, with the FY2025 full-year figure at $406.0, up 100.0% from the prior year.
- Retained Earnings advanced to $494.0 in Q1 2026 per NXL's latest filing, from $406.0 in the prior quarter.
- Across five years, Retained Earnings topped out at $80.2 million in Q4 2023 and bottomed at -$90.5 million in Q3 2025.
- The 5-year median for Retained Earnings is -$325.0 (2024), against an average of -$21.9 million.
- Across the five-year window, Retained Earnings surged 210.84% in 2023 and sank 27843243.38% in 2025, its largest moves.
- Year by year, Retained Earnings stood at -$72.4 million in 2022, then jumped by 210.84% to $80.2 million in 2023, then slumped by 205.49% to -$84.6 million in 2024, then surged by 100.0% to $406.0 in 2025, then rose by 21.67% to $494.0 in 2026.
- Per Business Quant, the three latest NXL Retained Earnings figures stand at $494.0 (Q1 2026), $406.0 (Q4 2025), and -$90.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -583.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -4.10 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 6.91 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 14.62 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.63 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -1.40 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.32 Bn |
| 10 | Nexalin Technology | 9.32 Mn | 6.61 Mn | 13,133.00 | 494.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 494.00 |
| Dec 31, 2025 | 406.00 |
| Sep 30, 2025 | -90.49 Mn |
| Jun 30, 2025 | -88.21 Mn |
| Mar 31, 2025 | 317.00 |
| Dec 31, 2024 | -84.65 Mn |
| Sep 30, 2024 | -325.00 |
| Jun 30, 2024 | -79.36 Mn |
| Mar 31, 2024 | -78.08 Mn |
| Dec 31, 2023 | 80.24 Mn |
| Sep 30, 2023 | 800.00 |
| Jun 30, 2023 | 77.91 Mn |
| Mar 31, 2023 | 77.82 Mn |
| Dec 31, 2022 | -72.39 Mn |
| Sep 30, 2022 | -71.66 Mn |
| Dec 31, 2021 | 69.00 Mn |